Last update:
Weight management news
Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes ...
1 hour ago
0
0
Circadian rhythm drives metabolic dysfunction in fat cells, study finds
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, have discovered how disruptions in ...
10 hours ago
0
0
Mediterranean diet protects against fractures while calorie restriction increases bone breakdown, study finds
A Mediterranean diet can significantly lower the risk of hip and overall fractures, according to a major new review from the University of Chester. Researchers from the University's Medical School have closely analyzed 30 ...
16 hours ago
0
0
Anti-obesity treatment could cost as little as $3 per month: Study
A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low- and ...
Mar 6, 2026
0
1
The weight of stress: Helping parents may protect children from obesity
In recent years, rates of childhood obesity have been rising, with the U.S. Centers for Disease Control estimating in 2024 that approximately one in five children and adolescents met the clinical definition of obese. But ...
Mar 6, 2026
0
0
Some patients keep weight off with fewer GLP-1 injections, study finds
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, according to a small new study.
Mar 6, 2026
0
1
Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, ...
Mar 5, 2026
0
1
How gut bacteria and diet can reprogram fat to burn more energy
Scientists at City of Hope and the Broad Institute and Keio University have discovered how specific gut bacteria work together with the diet to flip a metabolic switch—transforming energy-storing white fat into calorie-burning ...
Mar 4, 2026
0
0
Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last
A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing to keep off 25% ...
Mar 4, 2026
0
0
No more weekly injections? How lettuce cells could deliver GLP-1 pills
Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as a new oral delivery of two GLP-1 drugs previously approved by the FDA in injectable form.
Mar 4, 2026
0
2
GLP-1 weight-loss drugs comparably effective across age, race and starting weight
Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among patients of different ages, races, and starting weights, with women benefiting somewhat more than men, ...
Mar 4, 2026
0
0
Predictors of prediabetes/type 2 diabetes mellitus identified among U.S. adolescents
Male gender, younger age, and waist-to-height ratio are independent predictors of prediabetes/type 2 diabetes mellitus (T2DM) among U.S. adolescents, according to a study published online Feb. 25 in PLOS Global Public Health.
Mar 4, 2026
0
0
Emotions drive our eating choices
New research from Flinders University has revealed why many people struggle to stick to their dieting goals, particularly when their emotions fluctuate throughout the day. The study, published in the journal Food Quality ...
Mar 4, 2026
0
0
Twenty percent of eligible youth prescribed GLP-1 receptor agonists
Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher with increasing age, increasing body mass index (BMI), and non-Hispanic ...
Mar 4, 2026
0
0
Wearing a weighted vest to strengthen bones? Make sure you're moving
More time spent standing or stepping while wearing a weighted vest showed positive changes in bone mineral density, according to a new weight loss study from Wake Forest University. It's encouraging news for people trying ...
Mar 3, 2026
0
1
British children are growing taller but not for the right reasons
A new analysis of Child Measurement Program data from England, Scotland, and Wales challenges recent reports suggesting children in Britain are getting shorter. The analysis, conducted by researchers at the University of ...
Mar 3, 2026
0
0
Your lifestyle trajectory greatly influences your weight, study says
Today, almost a third of U.S. adults are overweight and 43% have obesity. Behaviors that are likely to influence weight may be cemented early on. Early adulthood, from ages 18 to 25, is a time when people tend to experience ...
Mar 3, 2026
0
0
CDC reports on prevalence of obesity, severe obesity in U.S. adults, children
The prevalence of obesity and severe obesity markedly increased among adults and children in the United States from the 1970s and 1980s until now, according to two reports published in the February Health E-Stats, a publication ...
Mar 2, 2026
0
0
Can you actually have a 'slow' or 'fast' metabolism?
Have you ever heard someone claim they have a fast metabolism? This typically means they can eat whatever they want without gaining weight. Meanwhile, others blame their inability to lose weight on having a slow metabolism.But ...
Mar 2, 2026
0
0
The science of Ramadan fasting
The month of Ramadan, which began last week, is when many Muslims around the world fast from dawn to sunset, refraining from food, drink, and other physical needs as an act of worship and self-discipline.
Mar 1, 2026
0
0
Brain scans reveal why you can't resist a snack, even when you're full
Research from the University of East Anglia (UEA) may finally explain why we still reach for the cookie jar, even when we're full. A new study reveals that the human brain continues to respond to tempting food cues even after ...
Feb 28, 2026
0
2
Virtual buffet points to variety as an overeating risk factor
At Super Bowl parties, weddings, Independence Day cookouts and Thanksgiving dinners, people celebrate with large spreads of food. When faced with many options, extra food variety increases people's selection of foods, especially ...
Feb 27, 2026
0
0
Muscle repair may hinge on a timed metabolic 'switch,' study suggests
Scientists at the University of California, Irvine's School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells "flip a switch" to rebuild damaged muscle—a finding that could help address muscle ...
Feb 27, 2026
0
0
Metabolic dysfunction is main driver of chronic kidney disease risk
Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in Nutrition & Diabetes.
Feb 27, 2026
0
0
Q&A: Prescription drug ads are everywhere. Is the 'ask your doctor' era over?
It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that includes a lengthy list of side effects and a prompt to speak with a doctor. And while these familiar ...
Feb 27, 2026
0
0
